Positive immunohistochemical (IHC) expression was noted in over 70% of BC cases for PIAS3 (cytoplasm), SOCS3, PRLR, and STAT5 antigens and in 68% of BC cases for PIP. This evidence concerns the gene PRLR and breast cancer.